The Italian Congress dedicated to #AYA with #cancer is about to start. We’ll talk about chronicity, pregnancy, education, architecture, risk factors, clinical trials, social reintegration, caregivers, LGBTQ+ and much more.
With the support of #AIOM and #AIEOP

📌 Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

sciencedirect.com/science/articl…
@oncoalert.bsky.socia#OncoAlertAFAF

Mechanisms of resistance to PARP inhibitors in advanced prostate cancer with BRCA2/PALB2 alterations: Reversion mutations emerge within 16 weeks. These associate with disease progression and survival.
#Cancer #Oncology @oncoalert.bsky.social @apccc.bsky.social
www.sciencedirect.com/science/arti...

Dr. Alisa Goldstein (Bethesda) on Cancer Risk for #ATM PV carriers at the #AIFET Congress
👇👇👇

The third National Congress of the Italian Society for Familial and Hereditary Tumors #AIFET is going to start in the wonderful Camogli!

(Let’s start a new adventure with 🦋)